Jun Jiang

Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis.

Xiaowei Qi, Yi Zhang, Qiyun Shi, 2022, Biochimica et biophysica acta. Reviews on cancer.

AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function

Yi Zhang, J. Wong, Jiwen Li, 2010, Cell Research.

Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria

Z. Shao, Yi Yang, X. Bian, 2023, Cell Research.

Identification of XAF1 as an endogenous AKT inhibitor.

H. Ji, Daming Gao, Dayun Lu, 2023, Cell reports.

Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now

Yi Zhang, Juncheng Xuhong, X. Qi, 2023, Breast Cancer Research.

Artificial intelligence-assisted ultrasound image analysis to discriminate early breast cancer in Chinese population: a retrospective, multicentre, cohort study

Jia Liu, Xin Wu, L. Chen, 2023, EClinicalMedicine.